Author

C. Negron

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:protein structure· 1 Approach:statistical model· 1

Frequent Co-Authors

J. D. Chodera· 1 shared K. Hauser· 1 shared L. Wang· 1 shared R. Abel· 1 shared S. K. Albanese· 1 shared S. Ray· 1 shared T. Steinbrecher· 1 shared

Activity by Year

2018-2018 · peak 1/yr

Co-Author Collaboration Network

7 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

J. D. Chodera

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Predicting resistance of clinical Abl mutations to targeted kinase inhibitors using alchemical free-energy calculations

K. Hauser, C. Negron, S. K. Albanese, S. Ray, T. Steinbrecher, R. Abel, J. D. Chodera, L. Wang

This paper uses alchemical free-energy calculations to predict how Abl mutations affect inhibitor affinity, achieving accurate results for clinical mutations.

bioRxiv · Apr 2, 2018Cancer Biology